| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.2 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |